More Videos:

Aug. 25 Premarket Briefing: 10 Things You Should Know

Tickers in this article: ANN BKW DIS GS ITMN MCD RHHBY SNE THI

NEW YORK ( TheStreet) -- Here are 10 things you should know for Monday, Aug. 25:

1. -- U.S. stock futures rose Monday following European stocks higher after European Central Bank President Mario Draghi signaled late on Friday that central bankers were prepared to tweak monetary policy if needed.

Asian stocks ended Monday's session mostly higher.

Read More: Why Apple's iPhone 6 Won't Be Late

2. -- The economic calendar in the U.S. on Monday includes new home sales for July at 10 a.m. EDT.

3. -- U.S. stocks on Friday finished flat on Friday but settled higher for the week.

The markets got what they were looking for in a speech from Federal Reserve Chief Janet Yellen on Friday - she stuck to the script on U.S. labor slack and her dovish outlook.

The Dow Jones Industrial Average declined 0.22% on Friday to 17,001.22. The S&P 500 fell 0.2% to 1,988.40. The Nasdaq rose 0.14% to 4,538.55.

4. -- Burger King is in talks to buy Tim Hortons , the Canadian coffee-and-doughnut chain, and form a new publicly listed company based in Canada.

The two fast-food companies announced Sunday that Burger King majority owner 3G Capital would continue to own the majority of shares of the new company, with the remainder held by shareholders of Tim Hortons and Burger King.

The two companies would continue to operate as separate brands but would share corporate services.

The Wall Street Journal first reported the news and said there's no guarantee a deal will happen.

A combined Burger King and Tim Hortons would have 18,000 restaurants in 100 countries with about $22 billion in sales. The companies said that would make it the world's third-largest fast-food restaurant company.

5. -- Roche announced Sunday an $8.3 billion acquisition of InterMune and its idiopathic pulmonary fibrosis drug Esbriet.

The all-cash deal values InterMune at $74 a share, or a 38% premium to Friday's closing stock price . Roche said the acquisition will be neutral to 2015 earnings and accretive in 2016.

InterMune's Esbriet is approved in Europe and is expected to be approved in the U.S. by Nov. 23 , based on the positive results of a phase III study .

6. -- Goldman Sachs agreed to a settlement worth $1.2 billion to resolve claims that it misled U.S. mortgage giants Fannie Mae and Freddie Mac about risky mortgage securities it sold them before the housing market collapsed in 2007.

The Federal Housing Finance Agency, which oversees Fannie and Freddie, announced the settlement Friday with Goldman, the Wall Street brokerage.

Goldman sold the securities to the companies between 2005 and 2007.

7. -- McDonald's is losing its luster with younger consumers, according to data compiled for the Journal by restaurant consultancy Technomic.